NVR LO (Tabrecta 200 mg)
Generic Name: capmatinib
Pill with imprint NVR LO is Yellow, Elliptical / Oval and has been identified as Tabrecta 200 mg. It is supplied by Novartis Pharmaceuticals Corporation.
Tabrecta is used in the treatment of non-small cell lung cancer and belongs to the drug class multikinase inhibitors. Tabrecta 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for NVR LO
Related Images for "NVR LO"
More about Tabrecta (capmatinib)
- During Pregnancy
- Dosage Information
- Imprints, Shape & Color Data
- Drug Interactions
- Drug class: multikinase inhibitors
- FDA Approval History
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.